BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32970335)

  • 21. Inactivation of CD73 promotes atherogenesis in apolipoprotein E-deficient mice.
    Buchheiser A; Ebner A; Burghoff S; Ding Z; Romio M; Viethen C; Lindecke A; Köhrer K; Fischer JW; Schrader J
    Cardiovasc Res; 2011 Nov; 92(2):338-47. PubMed ID: 21955554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model.
    Tsukui H; Horie H; Koinuma K; Ohzawa H; Sakuma Y; Hosoya Y; Yamaguchi H; Yoshimura K; Lefor AK; Sata N; Kitayama J
    BMC Cancer; 2020 May; 20(1):411. PubMed ID: 32397971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.
    Perrot I; Michaud HA; Giraudon-Paoli M; Augier S; Docquier A; Gros L; Courtois R; Déjou C; Jecko D; Becquart O; Rispaud-Blanc H; Gauthier L; Rossi B; Chanteux S; Gourdin N; Amigues B; Roussel A; Bensussan A; Eliaou JF; Bastid J; Romagné F; Morel Y; Narni-Mancinelli E; Vivier E; Paturel C; Bonnefoy N
    Cell Rep; 2019 May; 27(8):2411-2425.e9. PubMed ID: 31116985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5'-Ectonucleotidase/CD73 expression on lymph-circulating lymphocytes and lymphatic endothelial cells offers new paths to explore barrier function.
    Sidibé A; Imhof BA
    Eur J Immunol; 2015 Feb; 45(2):371-5. PubMed ID: 25641680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased efficacy of a dendritic cell-based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor.
    Arab S; Kheshtchin N; Ajami M; Ashurpoor M; Safvati A; Namdar A; Mirzaei R; Mousavi Niri N; Jadidi-Niaragh F; Ghahremani MH; Hadjati J
    Tumour Biol; 2017 Mar; 39(3):1010428317695021. PubMed ID: 28349824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD73 plays a protective role in collagen-induced arthritis.
    Chrobak P; Charlebois R; Rejtar P; El Bikai R; Allard B; Stagg J
    J Immunol; 2015 Mar; 194(6):2487-92. PubMed ID: 25681339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vivo Immunological Effects of CD73 Deficiency.
    Adam T; Mathes A; Isayev O; Philippov PP; Werner J; Karakhanova S; Bazhin AV
    Cell Physiol Biochem; 2019; 52(5):1192-1202. PubMed ID: 31001959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response.
    Koszalka P; Ozüyaman B; Huo Y; Zernecke A; Flögel U; Braun N; Buchheiser A; Decking UK; Smith ML; Sévigny J; Gear A; Weber AA; Molojavyi A; Ding Z; Weber C; Ley K; Zimmermann H; Gödecke A; Schrader J
    Circ Res; 2004 Oct; 95(8):814-21. PubMed ID: 15358667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation.
    Niemelä J; Henttinen T; Yegutkin GG; Airas L; Kujari AM; Rajala P; Jalkanen S
    J Immunol; 2004 Feb; 172(3):1646-53. PubMed ID: 14734746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular adenosine produced by ecto-5'-nucleotidase (CD73) regulates macrophage pro-inflammatory responses, nitric oxide production, and favors Salmonella persistence.
    Costales MG; Alam MS; Cavanaugh C; Williams KM
    Nitric Oxide; 2018 Jan; 72():7-15. PubMed ID: 29108754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
    Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
    BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD73-adenosine: a next-generation target in immuno-oncology.
    Allard D; Allard B; Gaudreau PO; Chrobak P; Stagg J
    Immunotherapy; 2016 Feb; 8(2):145-63. PubMed ID: 26808918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface.
    Rahimova R; Fontanel S; Lionne C; Jordheim LP; Peyrottes S; Chaloin L
    PLoS Comput Biol; 2018 Jan; 14(1):e1005943. PubMed ID: 29377887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perivascular CD73
    Perry HM; Görldt N; Sung SJ; Huang L; Rudnicka KP; Encarnacion IM; Bajwa A; Tanaka S; Poudel N; Yao J; Rosin DL; Schrader J; Okusa MD
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F658-F669. PubMed ID: 31364375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.
    Koszałka P; Gołuńska M; Urban A; Stasiłojć G; Stanisławowski M; Majewski M; Składanowski AC; Bigda J
    PLoS One; 2016; 11(3):e0151420. PubMed ID: 26964090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of CD73 associates with T cell exhaustion in AML patients.
    Kong Y; Jia B; Zhao C; Claxton DF; Sharma A; Annageldiyev C; Fotos JS; Zeng H; Paulson RF; Prabhu KS; Zheng H
    J Hematol Oncol; 2019 Apr; 12(1):40. PubMed ID: 31014364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD73-deficient mice are resistant to carcinogenesis.
    Stagg J; Beavis PA; Divisekera U; Liu MC; Möller A; Darcy PK; Smyth MJ
    Cancer Res; 2012 May; 72(9):2190-6. PubMed ID: 22396496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury.
    Hart ML; Henn M; Köhler D; Kloor D; Mittelbronn M; Gorzolla IC; Stahl GL; Eltzschig HK
    FASEB J; 2008 Aug; 22(8):2784-97. PubMed ID: 18353866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer.
    Loi S; Pommey S; Haibe-Kains B; Beavis PA; Darcy PK; Smyth MJ; Stagg J
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11091-6. PubMed ID: 23776241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.